Inhibition of Aspergillus parasiticus and cancer cells by marine actinomycete strains

Ten actinomycete strains isolated from the Yellow Sea off China's coasts were identified as belonging to two genera by 16 S r DNA phylogenetic analysis: Streptomyces and Nocardiopsis. Six Streptomyces strains(MA10, 2SHXF01-3, MA35, MA05-2, MA05-2-1 and MA08-1) and one Nocardiopsis strain(MA03) were predicted to have the potential to produce aromatic polyketides based on the analysis of the KSα(ketoacyl-synthase) gene in the type II PKS(polyketides synthase) gene cluster. Four strains(MA03, MA01, MA10 and MA05-2) exhibited significant inhibitory effects on mycelia growth(inhibition rate 50%) and subsequent aflatoxin production(inhibition rate 75%) of the mutant aflatoxigenic Aspergillus parasiticus NFRI-95. The ethyl acetate extracts of the broth of these four strains displayed significant inhibitory effects on mycelia growth, and the IC50 values were calculated(MA03: 0.275 mg m L-1, MA01: 0.106 mg m L-1, MA10: 1.345 mg m L-1 and MA05-2: 1.362 mg m L-1). Five strains(2SHXF01-3, MA03, MA05-2, MA01 and MA08-1) were selected based on their high cytotoxic activities. The ethyl acetate extract of the Nocardiopsis strain MA03 was particularly noted for its high antitumor activity against human carcinomas of the cervix(He La), lung(A549), kidney(Caki-1) and liver(Hep G2)(IC50: 2.890, 1.981, 3.032 and 2.603 μg m L-1, respectively). The extract also remarkably inhibited colony formation of He La cells at an extremely low concentration(0.5 μg m L-1). This study highlights that marine-derived actinomycetes are a huge resource of compounds for the biological control of aflatoxin contamination and the development of novel drugs for human carcinomas.     

副溶血性弧菌产耐热直接溶血毒素对黑色素瘤的抑制作用研究

为探讨耐热直接溶血毒素(Thermostabile direct hemolysin,TDH)在体内和体外对小鼠黑色素瘤细胞B16的抑制作用,本研究通过MTT法、克隆形成试验、凋亡试验、Caspase-8和Caspase-3的活性试验、线粒体膜电位的检测以及体内C57BL/6小鼠(Mus musculus)荷瘤实验,比较TDH作用于不同细胞的半抑制浓度(IC₅₀),评价TDH对小鼠黑色素瘤细胞B16的体内外抑制作用。结果发现:人结肠上皮细胞NCM460、人正常肝细胞LO2、人肝癌细胞SMMC-7721和小鼠黑色素瘤细胞B16在TDH处理24 h之后,细胞的半抑制质量浓度IC₅₀分别为151、118、54和48 μg/mL,正常细胞的IC₅₀高出癌细胞近2~3倍。当质量浓度低于20 μg/mL时,TDH以剂量依赖性的方式抑制B16细胞的克隆形成,6 mg/kg TDH在移植瘤模型中显著抑制体内肿瘤的生长(P<0.001)。流式细胞术和荧光试剂盒检测表明:20 μg/mL的TDH能诱导19.4%的B16细胞发生早期凋亡,并激活Caspase-8和Caspase-3,但不影响线粒体膜电位。TDH具有体内外的抗肿瘤活性,可能通过细胞表面的死亡受体介导的凋亡信号通路引起凋亡,从而发挥抗肿瘤作用。     

国外海洋抗肿瘤活性物质的研究与开发

海洋生物是抗肿瘤活性物质的重要来源。近十几年来，已从不同的海洋生物中分离鉴定了许多结构新颖的抗肿瘤活性物质，显示出诱人的研究开发前景。本文综述了目前国外从海洋动物、海洋植物和海洋微生物抗肿瘤活性物质的研究开发进展。     

藻类抗肿瘤活性物质研究进展

藻类中含有丰富的具有生物活性的代谢物，这些代谢物具有药理活性如抗肿瘤活性或可作为先导化合物。本文综述了藻类抗肿瘤活性物质的研究进展，同时也对其研究前景进行了展望。     

The antitumor effect of bromophenol derivatives in vitro and Leathesia nana extract in vivo

To investigate the antitumor effect of bromophenol derivatives in vitro and Leathesia nana extract in vivo, six bromophenol derivatives 6-(2,3-dibromo-4,5-dihydroxybenzyl)-2,3-dibromo-4,5-dihydroxy benzyl methyl ether (1), (+)-3-(2,3-dibromo-4,5-dihydroxyphenyl)-4-bromo-5,6-dihydroxy-1,3-dihydroisobenzofuran (2), 3-bromo-4-(2,3-dibromo-4,5-dihydroxybenzyl)-5-methoxymethyl-pyrocatechol (3),2,2',3,3'-tetrabromo-4,4',5,5'-tetrahydroxy-diphenylmethane (4), bis(2,3-dibromo-4,5-dihydroxybenzyl) ether (5), 2,2',3-tribromo-3',4,4',5-tetrahydroxy-6'-ethyloxymethyldiphenylmethane (6) were isolated from brown alga Leathesia nana, and their cytotoxicity were tested by MTr assays in human cancer cell lines A549, BGC-823, MCF-7, B16-BL6, HT-1080, A2780, Bel7402 and HCT-8. Their inhibitory activity against protein tyrosine kinase (PTK) with over-expression of c-kit was analyzed also by ELISA. The antitumor activity of ethanolic extraction of Leathesia nana (EELN) was evaluated on S180-bearing mice.All compounds showed very potent cytotoxicity against all of the eight cancer cell lines with IC50 below 10 μg/mL. In PTK inhibition study, all bromophenol derivatives showed moderate inhibitory activity and compounds 2, 5 and 6 showed significant bioactivity with the inhibition ratio of 77.5%, 80.1% and 71.4%,respectively. Pharmacological studies reveal that EELN could inhibit the growth of Sarcoma 180 tumor and increase the indices of thymus and spleen to improve the immune system remarkably in vivo. Results indicated that the bromophenoi derivatives and EELN can be used as potent antitumor agents for PTK over-expression of c-kit and considered in a new therapeutic strategy for treatment of cancer.     

吲哚并喹啉类似物的合成及抗肿瘤活性评价

建立了1种合成吲哚并喹啉羧酸化合物简便有效的方法。以邻氨基苯甲酸为起始原料,经酰化、缩合、环和、氯代、水解、还原多步反应得到6个吲哚并喹啉类似物。所合成化合物结构均经核磁共振及质谱技术验证,并利用MTT法测定了这6个吲哚并喹啉类似物对人乳腺癌细胞株MDA-231的体外扩增抑制活性。     

赤魟尾刺提取物的抗肿瘤作用

<正>赤魟Dasyatis akajei(Muller&henle)隶属于软骨鱼纲,下孔总目,鲼形目,魟科,魟属,常栖息于底质为泥沙的深潭中[1-3]。赤魟肉性味甘、咸平,有补气之功效。用其熬油,主治小儿疳积。尾刺研末入药,对治疗胃癌、食道癌、肺癌、乳腺炎、咽喉炎、疟疾、牙痛、魟鱼尾刺刺伤均有一定疗效[4]。赤魟尾刺含有多种毒素,有重要药理作用。涂洪斌等克隆出编码赤魟肿瘤抑制因子IPL的全长cDNA序列[5],并报道了赤魟亲环素A的融合表达、纯化及活性特征[6]。目前,赤魟尾刺的生物活性成分及其相关毒理和药理作用仍不清楚[7]。笔者研究了赤魟尾刺提取物(extracts of caudal spine,ECS)对小鼠可移植性肿瘤生长的影响,现将结果报告如下。     

The Antitumor Components from Marine-derived Bacterium Streptoverticillium luteoverticillatum 11014 Ⅱ

Eight known compounds were isolated from a marine-derived bacterium Streptoverticillium luteoverticillatum 11014 using bioassay-guided fractionations. Their structures were identified by spectral analysis as bis （4-hydroxybenzyl） ether （1）, p-hydroxyphenylethyl alcohol （2）, N-（4-hydroxyphenethyl） acetamide （3）, indole-3 carboxylic acid methyl ester （4）, dibenzo[b,e] [1,4]dioxine （5）, thymine （6）, cytosine deoxyribonucleoside （7） and 2, 3-butanediol （8）. These compounds were evaluated for their cytotoxic activities against K562 cell line with the SRB method for the first time. Compounds 2 and 4 showed cytotoxcities with IC50 values of 101.1 and 165.3 μolL^-1, respectively. All compounds were isolated from S. luteoverticillatum 11014 for the first time.     

The Cytotoxic Constituents from Marine-derived Streptomyces 3320^#

The present work studies the chemical constituents from marine-derived streptomyces 3320^# and their antitumor activities. The n-BuOH extract of the ferment broth of 3320^# was chromatographed on silica gel, Sephadex LH-20, ODS columns and HPLC to separate the compounds with antitoumor activities. Their structures were identified using IR, UV, NMR, MS spectroscopic techniques and compared with published data. The antitumor activities of the isolates were assayed using SRB method and flow cytometry assay, accompanied with the morphological observation of the cells under light micro- scope against mammalian tsFT210 cells. Ten compounds, cyclo-（Ala-Leu） 1, cyclo-（Ala-Ile） 2, cyclo-（Ala-Val） 3, cyclo- （Phe-Pro） 4, cyclo-（Phe-Gly）5, cyclo-（Leu-Pro）6, 1-methyl-1, 2, 3, 4-tetrahydro-β-carboline-3-carboxylic acid 7, N-（4- hydroxyphenethyl） acetamide 8, 4-methyoxy-l-（2-hydroxy） ethylbenzene 9 and uridine 10, were isolated from the ferment broth of streptomyces 3320^# . Among them, compounds 6, 7, 8 and 10 showed potent cytotoxicity against the tsFT210 cell with the IC50 values of 3.6, 7.2, 5.2 and 1.6 mmol L-1, respectively. Compounds 8, 10 also exhibited apoptosis inducing activity under 2.0 mmol L-1. Compounds 6, 7, 8 and 10 are the principle bioactive constituents responsible for the antitumor activities of marine streptomyces 3320^#. Compound 7 was isolated from this species for the first time.     

羊栖菜多糖抗肿瘤及其作用机制研究进展

羊栖菜(Sargassum fusiforme)多糖在多种肿瘤细胞系中表现出良好的抗癌活性,具有针对肿瘤细胞的选择活性和较小的毒副作用,可以作为现有肿瘤化疗药物的替代品进行开发。羊栖菜多糖主要通过诱导细胞凋亡作用于肿瘤细胞,其通过细胞周期停滞,增强机体免疫功能,改变细胞膜钙通道与流动性,破坏线粒体膜和产生一氧化氮来杀死癌细胞并防止转移。本文就国内外发表的羊栖菜多糖抗肿瘤功能及作用机制进行系统的归纳和总结,旨在为羊栖菜多糖抗肿瘤药物的深入研究、开发提供理论依据。